Aitken R John, Nixon Brett
Priority Research Centre for Reproductive Biology, Discipline of Biological Sciences, Faculty of Science and IT, University of Newcastle, and Hunter Medical Research Institute, Callaghan, NSW 2308, Australia.
Mol Hum Reprod. 2013 Dec;19(12):785-93. doi: 10.1093/molehr/gat067. Epub 2013 Sep 26.
Capacitation is a remarkable process whereby spermatozoa prepare themselves for engagement with the oocyte. Although the existence of this process has been appreciated as a biological phenomenon for more than half a century, its molecular underpinnings still await clarification. We know that some of the major changes involve sterol oxidation and efflux from the plasma membrane, the anterior movement of lipid rafts, changes in the surface expression of a variety of proteins including hyaluronidase and receptors for the zona pellucida, an increase in intracellular cyclic adenosine monophosphate (cAMP), the induction of tyrosine phosphorylation and the expression of hyperactivated motility. These changes are dependent on the presence of bicarbonate, to facilitate cAMP generation, maintain an alkaline intracellular pH and support an optimal level of reactive oxygen species generation and are enhanced by the presence of albumin to provide antioxidant protection to the plasma membrane and promote cholesterol efflux. In vivo, the rate at which sperm cells capacitate is carefully controlled in order to ensure that the release of capacitated spermatozoa from a post-insemination reservoir in the isthmic region of the oviduct is synchronized with ovulation. The factors that control these critical events are now being resolved, aided by proteomic studies that are providing critical definitive information on the range of receptors that exist in the sperm plasma membrane and define the manner in which these exquisitely complex cells interact with their environment. Progress in this area has been enhanced by IVF technology pioneered by Bob Edwards and will ultimately facilitate the design of safe, effective culture conditions for optimization of this revolutionary therapy.
获能是一个非凡的过程,通过这个过程精子为与卵母细胞结合做好准备。尽管这一过程作为一种生物学现象已被认识半个多世纪,但它的分子基础仍有待阐明。我们知道一些主要变化包括甾醇氧化和从质膜流出、脂筏向前移动、多种蛋白质(包括透明质酸酶和透明带受体)表面表达的变化、细胞内环状单磷酸腺苷(cAMP)增加、酪氨酸磷酸化的诱导以及超活化运动性的表达。这些变化依赖于碳酸氢盐的存在,以促进cAMP生成、维持细胞内碱性pH值并支持活性氧生成的最佳水平,而白蛋白的存在会增强这些变化,为质膜提供抗氧化保护并促进胆固醇流出。在体内,精子细胞获能的速率受到精确控制,以确保从输卵管峡部区域的授精后储存库中释放获能精子与排卵同步。在蛋白质组学研究的帮助下,控制这些关键事件的因素正在得到解决,蛋白质组学研究提供了关于精子质膜中存在的受体范围的关键确切信息,并确定了这些极其复杂的细胞与其环境相互作用的方式。由鲍勃·爱德华兹开创的体外受精技术推动了这一领域的进展,最终将有助于设计安全、有效的培养条件,以优化这种革命性疗法。